NARI250117P90000
- 0.00
- 0.000.00%
Inari Medical Newsroom
Vensana Capital Closes $425 Million Fund III to Back Breakthrough Medical Technology Companies
Analysts Offer Insights on Healthcare Companies: Cencora (COR) and Inari Medical (NARI)
Inari Medical(NARI.US) Director Sells US$12.09 Million in Common Stock
$Inari Medical(NARI.US)$ Director Hoffman William sold 200K shares of common stock on Jan 6, 2025 at an average price of $60.47 for a total value of $12.09 million.Source: Announcement What is
Is Inari Medical Inc. (NARI) Firm Posts Strong Gain Amid Wall Street Bloodbath?
Inari Medical (NASDAQ:NARI) Surges on Buyout From Stryker
A Quick Look at Today's Ratings for Inari Medical(NARI.US), With a Forecast Between $80 to $80
BTIG Downgrades Inari Medical to Neutral From Buy
Medical equipment manufacturer Inari (NARI.US) was acquired by a peer, and its stock price soared by 60% within two days.
USA medical device manufacturer Stryker (SYK.US) has agreed to acquire venous disease treatment company Inari Medical (NARI.US) for $4.9 billion in cash, at a price of $80 per share. The trade has been approved by both the Board of Directors and is expected to be completed in the first quarter. Inari's stock price rose over 30% on Monday (6th) on the day of the Reuters report regarding the news, and then rose another 22% to $79.45 last night (7th). The report cited sources indicating that Inari has been discussing the Ask with consultants in recent weeks, attracting interest from Stryker and other companies. As of last week, Inari's stock price was stopped.
The medical device company Stryker plans to acquire Inari for 4.9 billion US dollars.
On January 8, Glonghui reported that the medical device manufacturer Stryker announced it would acquire Inari Medical at a price of $80 per share, with a total transaction amount of approximately $4.9 billion. Stryker produces a variety of medical products, from hospital beds and other furniture to cleaning products, as well as orthopedic and neuro-surgical tools. Inari focuses on diseases such as venous thromboembolism or patients' venous thrombus, providing surgical products.
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Inari Medical, Inc. Buyout
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Sector Update: Health Care Stocks Advance Late Afternoon
Wells Fargo Downgrades Inari Medical to Equal-Weight, Raises Price Target to $80
Inari Medical Analyst Ratings
Top Midday Gainers
Penumbra Spikes After Stryker- Inari Deal
William Blair Downgrades Inari Medical to Market Perform
Hold Rating Issued for Inari Medical Amidst Stryker Acquisition With Minimal Antitrust Concerns and Reasonable Valuation
Stryker Stock Falls Despite the Agreement to Acquire Inari Medical
Express News | Inari Medical Inc : Jefferies Cuts to Hold From Buy